Short: Akers Biosciences reports $3.3M net loss

Akers Biosciences, a developer of rapid health information technologies, has reported its financial results for the fiscal year ended December 31, 2016.

The company has reported net loss of $3.3 million for the period. The loss has been decreased comparing to last years net loss of $9.3 million.